Mary Kay Ash Foundation ℠ Celebrates Five Years Shaping the Future of Cancer Research in Partnership With UT Southwestern Medical Center
The Mary Kay Ash Foundation℠, a decades-long leader and advocate for finding cures for cancers affecting women, and UT Southwestern Medical Center, one of the nation’s premier academic medical centers, in Dallas, Texas, are celebrating five years of collaborative success on the International Postdoctoral Scholars in Cancer Research Fellowship program. Hosted at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, the fellowship is a two-year postdoctoral program sponsored by the Mary Kay Ash Foundation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231107256704/en/
International Postdoctoral Scholars in Cancer Research, Class of 2023. Back Row: Dongqi Xie, Ph.D. (left), Principal Investigator Jerry Shay, Ph.D. (middle), Pedro Nogueira, Ph.D. (right); Front Row: Debora Andrade Silva, Ph.D. (left), Hong-Yi Liu, Ph.D. (middle), and Maria Del Chica Parrado, Ph.D. (right). (Photo: Mary Kay Inc.)
Established in 2019, the program set out to recruit exemplary international researchers in their respective fields, provide them with invaluable experience, mentorship, and a return grant to continue their pursuits in their home country - bringing their knowledge and experience gained with them.
To date, the program has successfully recruited 13 highly accomplished postdoctoral researchers from Brazil, China, Germany, Mexico, Singapore, Spain and Portugal - seven of which have successfully completed the program; six continue to actively pursue their respective research projects in Dallas; and all have made impactful contributions to notable research publications.
“For more than two decades, the Mary Kay Ash Foundation and UT Southwestern Medical Center have partnered in a continued commitment to find cures for cancers affecting women,” said Michael Lunceford, President, Mary Kay Ash Foundation Board of Directors. “Our partnership continues to bring pivotal innovations to the cancer research frontlines by removing barriers and encouraging information sharing across borders and the world. These findings will be shared on a global level and impact women in every corner of the world.”
Under the expert guidance of Dr. Jerry Shay, Professor of Cell Biology and The Southland Financial Corporation Distinguished Chair in Geriatrics at UT Southwestern Medical Center, the program has consistently attracted and recruited exceptional candidates, ensuring the participation of highly qualified individuals from diverse geographic areas. In the most recent recruitment efforts, two outstanding scholars were recruited to the program: Debora Andrade Silva, Ph.D., from the University of Sao Paulo in Brazil, and Quan Wang, Ph.D., from Shanghai Jiao Tong University in China.
“We appreciate Mary Kay Ash Foundation’s continued investment in UT Southwestern Medical Center and the future of cancer research. With the foundation’s support, we can attract top international candidates, bring them to our state-of-the-art facilities to work with accomplished mentors, and make great strides in research advancements,” said Dr. Jerry Shay. “The global postdoctoral grant allows diverse cancer research talent the opportunity to conduct cutting-edge cancer research at both UT Southwestern Simmons Cancer Center and back in their home country.”
The Mary Kay Ash Foundation is proud to continue its long legacy of making the world a safer, healthier place for women and their families.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231107256704/en/
Contact information
The Mary Kay Ash Foundation
marykay.com/newsroom
(+1) 972.687.5332 or media@mkcorp.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
